Childhood Seizures Begin in the Womb, New Research Reveals

Before the first seizure, before the distinctive spike-wave burst on an EEG, before a child shows any sign of trouble, the damage is already in progress. A single faulty calcium channel, inherited from a parent, begins its work early. Not in infancy. Not at birth. The trouble starts in embryonic tissue. Researchers at Baylor College of Medicine have traced the mechanism: a loss of function in a specific type of calcium channel doesn’t simply impair neurotransmitter release. It does that, certainly. But it does something else too, something unexpected. It sets off a cascading sequence of genetic and developmental events that reshape the brain’s circuitry months before a child experiences a seizure.

The research focuses on childhood absence epilepsy, a seizure disorder characterized by sudden behavioral arrest and rapid spike-wave discharges. The pattern arises in the thalamocortical circuits (neural pathways linking the thalamus and cortex that regulate consciousness and attention). Unlike convulsive seizures, absence seizures are brief; sometimes so brief a parent might miss them. A child stares. A few seconds pass. Then normal behavior resumes. Yet the cumulative impact on learning and attention can be significant.

The mutation affects P/Q-type calcium channels: molecular gates that control calcium flow into neurons and trigger neurotransmitter release. For decades, researchers knew that loss-of-function mutations in the gene encoding these channels (called CACNA1A in humans) were linked to childhood absence epilepsy. The assumption was straightforward: fewer calcium ions entering the presynaptic terminal means less neurotransmitter release, which disrupts the circuit’s excitability balance. But assumption and mechanism are not the same thing. What the Baylor team discovered runs much deeper.

It begins before birth.

Using a mouse model of the human condition, graduate student Samantha Thompson and colleagues traced what happens when a calcium channel mutation takes hold in the developing thalamus. They found something striking: “this surge in neuronal growth began before birth,” Thompson noted, underscoring that the disorder’s origins arise much earlier than the childhood onset of seizures would suggest. The team observed a thalamic neurogenesis (proliferation of new neurons) occurring 3-fold higher in mutant embryos than in healthy littermates when measured during pregnancy. By birth, their thalamic nuclei contained roughly 24 percent more neurons than normal.

That developmental restructuring is paired with something else: coordinate upregulation of two genes that encode ion channels directly implicated in generating absence seizure patterns. One, Cacna1g, produces T-type calcium channels. The other, Kcnma1, produces what researchers call BK potassium channels. These two channels share membrane nanodomains (physically close neighborhoods on the neuron’s surface) where they interact to regulate bursting behavior. In the mutant thalamus, both are substantially overexpressed. And that overexpression begins early, detectable in the thalamus by day P14, several days before seizures first appear.

What’s remarkable is that this dual upregulation happens without a direct defect in the thalamic neurons themselves. In a clever conditional mutant, the researchers deleted P/Q channels only from a specific group of cortical projection neurons (the layer-6 pyramidal neurons that send descending signals to the thalamus). The thalamic relay cells themselves still had normal P/Q channels. Yet they still showed the same elevation in T-type and BK channel transcripts. This transsynaptic effect suggests that abnormal presynaptic signaling patterns from the defective cortical input alone are sufficient to reprogram the developing thalamic neurons’ gene expression, driving them down a pathogenic trajectory.

The mechanism linking P/Q channel loss to this transcriptional remodeling involves the Wnt signaling pathway, specifically the β-catenin/Lef1 complex. This is a growth-promoting system active during early brain development. In the tottering mutant mice (the classical genetic model carrying the P/Q channel defect), the researchers observed a 2-fold elevation in β-catenin expression and activation of the Lef1 transcription factor, which binds directly to the promoter regions of Cacna1g. More than 80 percent of mutant thalamic neurons showed coordinate elevation of all three components: Cacna1g, β-catenin, and Lef1. This activation of a developmental growth pathway may explain not only the excessive neurogenesis but also the sustained elevation of seizure-related ion channels. Early disruption of a homeostatic balance between growth and excitability appears to have set the stage for a circuit malfunction that persists into adulthood.

The finding carries profound implications for understanding how developmental disorders can originate. Many neurodevelopmental conditions involving seizures also feature cognitive impairment and attention problems. Children with absence epilepsy show high rates of attention deficit disorder, a comorbidity that has puzzled researchers for years. The enlarged thalamus described in this research might contribute to that cognitive burden. Perhaps the excessive neurogenesis, with its consequence of altered microcircuit connectivity, disrupts the thalamic filtering of sensory information and attentional priority. Perhaps the structural changes reshape the corticothalamic feedback loops that normally help suppress irrelevant stimuli. The research suggests that therapeutic approaches targeting only the acute seizure (blocking T-type channels with drugs, for instance) might be incomplete. An intervention aimed at the earlier developmental steps, at the growth pathways themselves, could theoretically prevent the circuit disruption before it becomes entrenched.

Of course, the leap from mouse models to human therapeutics is substantial. The researchers are cautious, appropriately so. They note that understanding how these genetic pathways interact at the cellular level remains complex. But “these insights open the door to earlier diagnostics and more targeted therapies,” Dr. Jeffrey Noebels, director of the developmental neurogenetic laboratory, said in a statement. The possibility of identifying at-risk infants before seizures begin (through genetic screening or neuroimaging biomarkers that detect the structural changes) is no longer purely speculative. And the identification of multiple converging pathways (the P/Q channel itself, the T-type and BK channels, the Wnt growth signal) offers multiple potential intervention points rather than a single rate-limiting step.

What emerges from this work is a picture of epilepsy as not simply a circuit malfunction appearing at seizure onset, but as a neurodevelopmental disorder whose roots extend into prenatal life. The distinction matters. It means that the window for intervention may be much wider than clinicians have assumed. It suggests that absence epilepsy, in some cases, might be preventable if the early developmental cascade could be interrupted. The authors emphasize that their findings apply specifically to one genetic form of childhood absence epilepsy, but the principle (that ion channel mutations reshape developmental trajectories, not just electrical signaling) may extend to other channelopathies and neurodevelopmental disorders. For now, in the laboratories continuing this work, that possibility remains the most tantalizing question: not how to treat a disorder once the circuit is broken, but how to prevent the breaking in the first place.

Source: https://www.cell.com/neuron/fulltext/S0896-6273(26)00179-0